http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104968667-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 |
filingDate | 2014-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2017-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2017-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-104968667-B |
titleOfInvention | tetracycline kinase inhibitors |
abstract | The present invention belongs to the field of medical technology, and specifically relates to tetracycline kinase inhibitors represented by general formula (I) or stereoisomers thereof, or pharmaceutically acceptable salts, esters or solvates thereof, wherein A 1 , A 2 , A 3 , A 4 , R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , M, X, Y, Q and n are as defined in the specification. The present invention also relates to the preparation methods of these compounds, the pharmaceutical preparations and pharmaceutical compositions containing these compounds, and the compounds or their stereoisomers, or their pharmaceutically acceptable salts, esters or solvates in the preparation of therapeutic and/or Use in drugs for the prevention of cancer-related diseases mediated by ALK. |
priorityDate | 2013-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 585.